Richard J. Honeywell

20072019
If you made any changes in Pure these will be visible here soon.

Research Output 2007 2019

  • 50 Article
  • 4 Meeting Abstract
  • 2 Comment/Letter to the editor
  • 1 Review article
Filter
Meeting Abstract
2017

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

2014

High-dose, intermittent sunitinib as an alternative treatment strategy

Rovithi, M., de Haas, R. R., Honeywell, R. J., Voortman, J., Griffioen, A. W., Labots, M., Luik, A. M., Peters, G. J., Broxterman, H. J. & Verheul, H. M. W., 1 Oct 2014, In : Cancer Research. 74, 19

Research output: Contribution to journalMeeting AbstractAcademic